BIT's 14th Annual Congress of International Drug Discovery Science & Technology
Past Conference Report

Past Conference Report of IDDST-South Korea 2016

BIT's 14th Annual Congress of International Drug Discovery Science and Technology-South Korea 2016 (IDDST-South Korea 2016), held in Korea International Exhibition Center (KINTEX), Gyeonggi, South Korea on June 16-18, achieved a consummation. The theme of this conference is “Overcoming the Barriers in New Therapeutic Innovation". Over 150 honored guests presented at the ceremony and gave brilliant speeches on invitation, among them are Dr. Chris H. Senanayake, Vice President of Department of Chemical Development in Boehringer Ingelheim Pharmaceuticals, Inc.; Dr. Bruce Given, COO of Arrowhead Research Corporation; Dr. Joseph P. Thomas, Chair of the Life Sciences Group and Co-chair of the Litigation Department in Ulmer & Berne LLP; Mr. Sean Hall, CEO of Medlab Clinical Ltd.; Dr. Seonggu Ro, Executive Vice President & CTO in CrystalGenomics, Inc. …etc.

This annual congress comprised 7 Parts and 20 sessions following the ceremony, including “Medicinal Chemistry"; "Pharmacology and Toxicology"; “Drug Delivery"; “Generics"; "Biologics Drugs"; "From Disease Clinical Research to Drug Development and Application"; "Young Scientist Forum"…etc.

This annual conference brought together 150 specialists from 35 countries and areas, which was devoted to the leading issues and popular topics and provide up-to-date information to all over the world. Depending on the warmly support and good suggestions from all of the participants, we are quite confident in organizing IDDST-2017 which would be better and more successful than IDDST-2016. All of us are looking forward to meeting you again in 2017.

Conference Pictures

Opening Ceremory1

Opening Ceremory2

Opening Ceremory3

Welcome Banquet1

Welcome Banquet2

Welcome Banquet3

Parallel Sessions1

Parallel Sessions2

Parallel Sessions3

Parallel Sessions4

Parallel Sessions5

Parallel Sessions6

Standing Lunch1

Standing Lunch2

Standing Lunch3

Coffee Break1

Coffee Break2

Coffee Break3
About Conference

Since its stage established in 2003, the annual IDDST Congress has differentiated itself as a major event updating the breaking research of drug discovery and development for both academic and industrial professionals with strong scientific program ever since. As a branded Conference of BIT Congress, IDDST continues to expand with magnificent scientific and social programs to maximize your network in a free communication meeting environment. And now, the New Era of IDDST-South Korea 2016 will begin in Gyeonggi, South Korea!

Renowned Speakers of IDDST-South Korea 2016
Dr. Chris H. Senanayake, Vice President, Boehringer Ingelheim Pharmaceuticals, Inc., USA Dr. Bruce Given, COO, Arrowhead Research Corporation, US Dr. Joseph P. Thomas, Chair of the Life Sciences Group and Co-chair of the Litigation Department, Ulmer & Berne LLP, USA Mr. Sean Hall, CEO, Medlab Clinical Ltd., Australia Dr. Seonggu Ro, Executive Vice President & CTO, CrystalGenomics, Inc., South Korea Dr. Frank Roschangar, Director, Process Research & Global External Chemistry Management, Chemical Development US, Boehringer Ingelheim Pharmaceuticals, Inc., USA Dr. Volodymyr Kysil, Director of Chemistry, ChemDiv, Inc., USA Dr. Nils Hansen, CEO, Vipergen ApS, Denmark Dr. Raphael Nudelman, Associate Director, Head of Chemical & Computational Toxicology, Teva Pharmaceutical Industries Ltd., Israel Dr. Jianxun Xie, Head of Toxicology, Roche Innovation Center Shanghai, China Dr. Olivier Bezencon, Senior Group Leader, Actelion Pharmaceuticals Ltd., Switzerland Dr. Daniel Galbraith, Chief Scientist, Sartorius Stedim BioOutsource Ltd., UK Dr. Cyrus Khojasteh, Associate Director, Genentech, Inc., USA Mr. Avner Gal, President & CEO, Integrity Applications Ltd., Israel Dr. Mats Andersson, Founder and Chief Scientific Officer, Viscogel AB, Sweden Dr. Xujin Lu, Senior Principal Scientist, Bristol-Myers Squibb Company, USA Dr. Wen Zeng, President and CEO, Sichuan Primed Bio-tech Group Co., Ltd., China Mr. Mike Nelson, Partner, HGF Limited, UK Dr. Olaf Schoepke, Director of Strategic Development, Samarind Limited, UK Dr. Hak Jong Lee, Professor, Seoul National University, South Korea Dr. Xiang-Qun Xie, Associate Dean and Professor, School of Pharmacy, University of Pittsburgh, USA Dr. Pierre Vogel, Professor, Swiss Institute of Technology in Lausanne (EPFL), Switzerland Dr. Patrick Y. S. Lam, Adjunct Professor, Drexel University College of Medicine, USA Dr. Pavel Hobza, Professor, Institute of Organic Chemistry and Biochemistry AS CR, v.v.i., Czech Republic Dr. Dimiter S. Dimitrov, Senior Investigator, National Cancer Institute, NIH, USA Dr. Xinyuan Liu, Professor, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, China Dr. Hongtao Jin, Vice Director, New Drug Safety Evaluation Center (NDSEC), PUMC&CAMS; Beijing Union-Genius Pharma China Dr. Pierre Eftekhari, Founder and Director, Inoviem Scientific, Strasbourg University, France Dr. Shuji Kitagawa, President, Kobe Pharmaceutical University, Japan Dr. Randolph D Glickman, Professor, University of Texas Health Science Center, USA
Speaking Opportunity

Over 300 highly respected industrialists and academic, key regulators and management gurus will join in this three-day congress. The congress hereby invites groups and individuals to submit proposals for sessions (i.e. keynote & plenary lectures, symposia, workshops, etc.) for the scientific program. Interest groups are also welcome to organize independent pre- or post-congress Satellite meetings, which is different from session proposals for the program.

Sponsorship and Exhibit

The conference offers a variety of co-sponsorship and exhibition packages, customized to meet your company's needs. Contact us today to secure your place at this year's conference! Participating as an exhibitor or sponsor will provide you excellent exposure and network with 200 decision makers! The conference offers a customized package to meet your company's needs.

Scenery of South Korea

Located in the mid-western part of the Korean peninsula, Gyeonggi-do Province is home to a large variety of tourist destinations, including cultural heritage sites (Suwon Hwaseong Fortress, Korea Folk Village, Icheon Cerapia), theme parks (Seoul Land in Gwacheon, Everland in Yongin), the Demilitarized Zone, and nature conservation sites


Hosting Organization
BIT Group Global Ltd.
Foreign Experts Databank of SAFEA-Dalian Branch
Supporting Organizations

Goyang City

Gyeonggi MICE Bureau

Gyeonggi Tourism Organization
Official Travel Agency
Media Partners

Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China]
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2015-2016 BIT Group Global Ltd.